RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q2 2021 Results - Earnings Call Transcript

Revance Therapeutics, Inc. (RVNC) Q2 2021 Earnings Conference Call August 05, 2021, 04:30 PM ET Company Participants Jessica Serra - Head, IR and ESG Mark Foley - President and CEO Toby Schilke - CFO Dr. Abhay Joshi - COO and President, R&D and Product Operations Dustin Sjuts - Chief Commercial Officer, Aesthetics and Therapeutics Aubrey Rankin - President, Innovation and Technology Conference Call Participants Seamus Fernandez - Guggenheim Terence Flynn - Goldman Sachs Annabel Samimy - Stifel David Amsellem - Piper Sandler Tim Lugo - William Blair Balaji Prasad - Barclays Serge Belanger - Needham & Company Ken Cacciatore - Cowen Vamil Divan - Mizuho Chris Bialas - H. C. Wainright Presentation Operator Good day, everyone. Welcome to Revance Therapeutics Second Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, August 5, 2021. I would now like to turn

For further details see:

Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q2 2021 Results - Earnings Call Transcript